PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2017 | nr 1 | 43--47
Tytuł artykułu

Reimbursement and Value Assessment Frameworks: Ensuring Patients' Access to Asthma Medicines in Ukraine

Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Background. Health technology assessment (HTA) introduction and implementation for development of the National List of Essential Medicines (NLEM) took place in Ukraine in 2016 in the context of National Drug Policy until 2025. The study aimed to outline the reimbursement of medicines for asthma treatment, market access for innovative medicines, main steps of HTA development in the decision making process in Ukraine in line with the international requirements and future directions. Methods. Literature review was conducted examining legislation database and scientific publications on the study issues in Ukraine: epidemiology of asthma, reimbursement programs, HTA development, affordability of innovative medicines for asthma treatment, market analysis. The study was performed to investigate the practices, processes and policies of value assessment and their impact in Ukraine. Results. In 2016 a legal framework was developed for the elaboration of NLEM and procedures for reference pricing and reimbursement programs. HTA is used for the inclusion medicines on the list based on the applied evidence of quality, efficacy, effectiveness, safety and economic evaluations adhering to the Order of Ministry of Health (MoH). HTA implementation in 2016 consisted of legislation, HTA training for experts of Expert committee of MoH and development of NLEM. Reimbursement programs for cardiovascular diseases, type 2 diabetes (T2D), asthma have started in April 2017 due to the adopted regulations. Conclusions. HTA use in the decision-making in Ukraine will provide an access to innovative medicines for patients and transparent, consistent decision making process in assessing the health technologies for inclusion on regulatory lists and reimbursement programs.(original abstract)
Rocznik
Numer
Strony
43--47
Opis fizyczny
Twórcy
autor
  • Lviv National Medical University
  • Lviv National Medical University
autor
  • Ministry of Health of Ukraine, Kyiv
  • Ukrainian Center for Scientific Medical Information and Patent License of Ministry of Health of Ukraine, Kyiv
Bibliografia
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2016. Available from: http://ginasthma.org/
  • Linnyk M.I., Nedospasova O.P., Tarasova O.R., Bushara I.V., Nikiforova L.G. Comparative data on the prevalence of respiratory diseases and medical assistance to patients with allergic disease and pulmonological profile in Ukraine for 2009-2015. Edited by
  • Brozek G., Zejda J., Fedortsiv O., Shpakou A., Hryshchuk L. et al. Belarus Ukraine Poland Asthma Study (BUPAS) - Prevalence of asthma, respiratory symptoms and allergic diseases in children. European Respiratory Journal. 2012; 40(52): 46-62.
  • Antypkin Yu.G., Chumachenko N.G., Umanets T.R., Lapshyn V.F. Analysis of the incidence and prevalence of asthma in children of different age groups in Ukraine. Perinatol and pediatr. 2016; 1(65): 95-99.
  • Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington. 2016. - Available from: http://vizhub.healthdata.org/gbd-compare.
  • Order of MoH dated 08.10.2013 №868 "On approval and introduction of medical and technological documents on standardization of care in asthma" - Available from: http://mtd.dec.gov.ua/index.php/uk/ reiestr-mtd/item/7-bronkhialna-astma.
  • Resolution of the Cabinet of Ministers of Ukraine dated 09.11.2016, № 862. Available from: http://www. apteka.ua/article/393206.
  • Resolution of the Cabinet of Ministers of Ukraine dated 09.11.2016, № 863. Available from:http://www. apteka.ua/article/393210.
  • Order of MoH dated 11.02.2016 № 84. Available from: http://www.apteka.ua/article/362317.
  • Order of MoH dated 11.02.2016 № 1050. Available from: http://www.apteka.ua/article/390509.
  • Feshchenko Y.I. New approaches to the diagnosis and treatment of asthma and chronic obstructive pulmonary disease. Theoretical and practical J. «Asthma and allergy». 2016; 4: 34-44.
  • Kucharczyk A., Mazurek J., Jahnz-Rozyk K. Severe allergic asthma treatment in Poland. Journal of Health Policy&Outcomes Research. 2016; 2. - Available from: http://www.jhpor.com/index/artykul/pokaz/ severe_allergic_asthma_treatment_in_poland.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.ekon-element-000171492632

Zgłoszenie zostało wysłane

Zgłoszenie zostało wysłane

Musisz być zalogowany aby pisać komentarze.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.